Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × PD-1 × toripalimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Advanced Solid Tumor 9 Solid Tumor 5 Uterine Cervical Neoplasms 4 Nasopharyngeal Carcinoma 4 Carcinoma, Non-Small-Cell Lung 4 Triple Negative Breast Neoplasms 3 Melanoma 3 Carcinoma, Hepatocellular 3 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neoplasms 2 Locally Advanced or Metastatic Solid Tumors 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Advanced Solid Tumors 2 Advanced Lung Cancer 2 Stomach Neoplasms 1 Solid Tumor, Adult 1 Solid Cancer 1 Sarcoma 1 Pyloric Stenosis, Hypertrophic 1 Pancreatic Neoplasms 1 Pancreatic Cancer Metastatic 1 PD-1 1 Ovarian Neoplasms 1 Meningeal Carcinomatosis 1 Lymphoma, Large B-Cell, Diffuse 1 Liver Neoplasms 1 Liposarcoma 1 Head and Neck Squamous Cell Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04061928 2019-08-20

Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ

Peking University

Phase 1/2 Unknown

Gastrointestinal

PD-1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡